Bovilis Cryptium RSS Authorised This medicine is authorised for use in the European Union cryptosporidium parvum, glycoprotein gp40 Medicine Veterinary Authorised
Page contentsPage contents Overview Product details Authorisation details Assessment history News on Bovilis Cryptium More information on Bovilis Cryptium Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Product details Name of medicine Bovilis Cryptium Active substance Cryptosporidium parvum, glycoprotein gp40 International non-proprietary name (INN) or common name cryptosporidium parvum, glycoprotein gp40 Pharmacotherapeutic groupImmunologicals for BovidaeInactivated parasitic vaccines Authorisation details EMA product number EMEA/V/C/006045 Assessment history Initial marketing authorisation documents CVMP summary of positive opinion for Bovilis CryptiumReference Number: EMA/CVMP/416566/2023 English (EN) (132.54 KB - PDF)First published: 06/10/2023 View News on Bovilis Cryptium Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 October 202306/10/2023 More information on Bovilis Cryptium Bovilis Cryptium - direct animal healthcare professional communication (DaHPC) This page was last updated on 03/04/2024 Share this page